Stock screenerAll disclosures →
EDGAR →
FTLF
Conviction 38HealthcareScan · Thu, Jun 25, 2026Hanging man
FTLF$11.83-0.67%
ResistanceSupportVol 14Insider buy2
Vol MA14 44.81K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price11.83
Change-0.67%
Gap-0.42%
Rel volume10.16×
Avg volume39.51K
Avg $ vol439.57K
SMA 2010.69
SMA 5010.05
SMA 20014.93
Price vs 50+17.72%
Price vs 200-20.74%
MA stackmixed
50/200 cross—
Supertrendup · 9.51
RSI (14)61
MACD hist0.14
MACD cross—
Stoch %K / %D70 / 75
ADX (14)27
+DI / −DI29 / 12
RSI divergence—
MACD divergence—
ATR %+7.04%
ADR %7.16%
52w high20.76
52w low8.88
From 52w high-43.02%
Above 52w low+33.22%
New 52w highNo
SqueezeOff
Bollinger width25.74%
%B0.91
Donchian pos71.30%
Donchian high12.77
Donchian low9.51
AVWAP (52w high)13.01
vs AVWAP high-9.07%
AVWAP (52w low)10.24
vs AVWAP low+15.52%
OBV trendDown
Chaikin MF (20)0.22
Today vs 20d10.16×
Avg vol (14d)44.81K
Avg vol (20d)39.51K
Avg $ vol (20d)439.57K
Market cap111.1M
RS 3m (vs SPY)-19.21%
RS 6m (vs SPY)-37.18%
RS line new highNo
Trend template2/8
Technical rank45.5
1 week+11.50%
1 month+19.13%
3 months-11.91%
6 months-30.29%
1 year-7.87%
YTD-24.94%
P/E17.56
P/B2.45
P/S5.11
P/FCF15.02
EPS0.6300
Div yield—
ROE13.94%
ROA6.07%
Debt/Eq1.02
Current1.52
EV/EBITDA14.23
Gross margin144.65%
Net margin29.09%
Rev growth11.52%
EPS growth-29.59%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value149.13M
Revenue6.71M
Net income1.72M
Gross profit9.52M
Free cash flow7.4M
IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
ExchangeNasdaq
Shares out9.39M
Employees81
ListedTue, Sep 25, 2007
Free float3.29M
Float %35.1%
Short interest203.64K
Days to cover6.4d
Short volume90.2%
Squeeze score72 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.17 vs $0.14
Last surprise+21.4% beat
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank45.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHanging man
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in FTLF
No recent disclosed trades by Congress in FTLF. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in FTLF · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hansen Ryan P. President · Performance Stock Units · 2026-05-15 | Grant | 50K | — | 2026-05-15 | 2026-05-19 |
Hansen Ryan P. President · Stock Options · 2026-05-15 | Grant | 28.5K | — | 2026-05-15 | 2026-05-19 |
Hansen Ryan P. President · Stock Options · 2026-05-15 | Grant | 46.5K | — | 2026-05-15 | 2026-05-19 |
Yakatan Seth Director · Common Stock · 2026-01-15 | Buy | 164 | $3K | 2026-01-15 | 2026-04-20 |
Lingenbrink Matthew Director · Common Stock · 2026-04-10 | Buy | 3K | $29K | 2026-04-10 | 2026-04-14 |
Dawson Grant Robert Director · Common Stock · 2026-04-10 | Buy | 3K | $30K | 2026-04-10 | 2026-04-14 |
SEC filings
EDGAR filings in FTLF
No recent SEC filings on file for FTLF.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.